CN Patent

CN110339341A — 一种达托霉素或其盐的组合物

Assigned to Jiangsu Hengrui Medicine Co Ltd · Expires 2019-10-18 · 7y expired

What this patent protects

本发明提供了一种达托霉素或其盐的组合物。具体而言，本发明涉及医药领域，提供了一种包含肌醇作为赋形剂的达托霉素制剂，其具有更好的稳定性和重建速率，进而能够提高其抗菌疗效。

USPTO Abstract

本发明提供了一种达托霉素或其盐的组合物。具体而言，本发明涉及医药领域，提供了一种包含肌醇作为赋形剂的达托霉素制剂，其具有更好的稳定性和重建速率，进而能够提高其抗菌疗效。

Drugs covered by this patent

Patent Metadata

Patent number
CN110339341A
Jurisdiction
CN
Classification
—
Expires
2019-10-18
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Hengrui Medicine Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.